ArticleBMC cancer2022

Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies.

Max Czajkowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.